Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis

Multiple sclerosis (MS) is a T-cell-mediated disease of the central nervous system, characterized by damage to myelin and axons, resulting in progressive neurological disability. Genes may influence susceptibility to MS, but results of association studies are inconsistent, aside from the identification of HLA class II haplotypes. Whole-genome linkage screens in MS have both confirmed the importance of the HLA region and uncovered non-HLA loci that may harbor susceptibility genes. In this two-stage analysis, we determined genotypes, in up to 672 MS patients and 672 controls, for 123 single-nucleotide polymorphisms (SNPs) in 66 genes. Genes were chosen based on their chromosomal positions or biological functions. In stage one, 22 genes contained at least one SNP for which the carriage rate for one allele differed significantly (P<0.08) between patients and controls. After additional genotyping in stage two, two genes—each containing at least three significantly (P<0.05) associated SNPs—conferred susceptibility to MS: LAG3 on chromosome 12p13, and IL7R on 5p13. LAG3 inhibits activated T cells, while IL7R is necessary for the maturation of T and B cells. These results imply that germline allelic variation in genes involved in immune homeostasis—and, by extension, derangement of immune homeostasis—influence the risk of MS.

[1]  B. Weinshenker,et al.  Association of two variants in IL-1β and IL-1 receptor antagonist genes with multiple sclerosis , 2000, Journal of Neuroimmunology.

[2]  S. Hannier,et al.  Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II , 1998, Immunogenetics.

[3]  R. Jonsson,et al.  A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans , 2002, Nature Genetics.

[4]  D. Altshuler,et al.  The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. , 2003, Annual review of genomics and human genetics.

[5]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[6]  L. Peltonen,et al.  A meta-analysis of whole genome linkage screens in multiple sclerosis , 2003, Journal of Neuroimmunology.

[7]  P. Sham,et al.  Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.

[8]  A. Sadovnick,et al.  The role of genetic factors in multiple sclerosis susceptibility , 1994, Journal of Neuroimmunology.

[9]  S. Sawcer,et al.  Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis , 2000, Journal of Neuroimmunology.

[10]  M. Ronaghi,et al.  A Sequencing Method Based on Real-Time Pyrophosphate , 1998, Science.

[11]  D. Curtis,et al.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci , 1995, Annals of human genetics.

[12]  P. Arner,et al.  Large‐scale genotyping of single nucleotide polymorphisms by Pyrosequencing™ and validation against the 5′nuclease (Taqman®) assay , 2002 .

[13]  G. Abecasis,et al.  A general test of association for quantitative traits in nuclear families. , 2000, American journal of human genetics.

[14]  T. Fry,et al.  Interleukin-7: from bench to clinic. , 2002, Blood.

[15]  G. Stewart,et al.  Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-α gene and their associations with multiple sclerosis , 2003, European Journal of Human Genetics.

[16]  Judy H. Cho,et al.  [Letters to Nature] , 1975, Nature.

[17]  J. Haines,et al.  The genetic epidemiology of multiple sclerosis , 2003, Journal of Neuroimmunology.

[18]  M. Ramanathan,et al.  In vivo gene expression revealed by cDNA arrays: the pattern in relapsing–remitting multiple sclerosis patients compared with normal subjects , 2001, Journal of Neuroimmunology.

[19]  J. Beckmann,et al.  A highly significant association between a COMT haplotype and schizophrenia. , 2002, American journal of human genetics.

[20]  G. Satten,et al.  Inference on haplotype effects in case-control studies using unphased genotype data. , 2003, American journal of human genetics.

[21]  M. Goldsmith,et al.  Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency. , 1997, The Journal of clinical investigation.

[22]  J. Gilbert,et al.  SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. , 2000, American journal of human genetics.

[23]  M. Kotze,et al.  Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. , 2001, Blood cells, molecules & diseases.

[24]  In-Jeong Kim,et al.  Lymphocyte Activation Gene-3 (CD223) Regulates the Size of the Expanding T Cell Population Following Antigen Activation In Vivo1 , 2004, The Journal of Immunology.

[25]  Bernhard Hemmer,et al.  A point mutation in PTPRC is associated with the development of multiple sclerosis , 2000, Nature Genetics.

[26]  J. Trent,et al.  Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  N. Burdin,et al.  Maturation and Activation of Dendritic Cells Induced by Lymphocyte Activation Gene-3 (CD223)1 , 2002, The Journal of Immunology.

[28]  R. Gold,et al.  Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. , 2002, Archives of neurology.

[29]  B. Ferry,et al.  Does 77→G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? , 2001, Nature Genetics.

[30]  I. Weissman,et al.  Induction of germline transcription in the TCRgamma locus by Stat5: implications for accessibility control by the IL-7 receptor. , 1999, Immunity.

[31]  S. Sawcer,et al.  Osteopontin gene and clinical severity of multiple sclerosis , 2003, Journal of Neurology.

[32]  V. Giedraitis,et al.  Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation , 2001, Journal of Neuroimmunology.

[33]  H. Lassmann.  Neuropathology in multiple sclerosis: new concepts , 1998, Brain research bulletin.

[34]  Laurent Excoffier,et al.  Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm , 1996, Heredity.

[35]  C. Polman,et al.  Association of interleukin-1β and interleukin-1 receptor antagonist genes with disease severity in MS , 1999, Neurology.

[36]  J. Kurtzke.  Epidemiologic evidence for multiple sclerosis as an infection , 1993, Clinical Microbiology Reviews.

[37]  Stephen L Hauser,et al.  Multiple sclerosis: Genomic rewards , 2001, Journal of Neuroimmunology.